A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01273480
Recruitment Status : Completed
First Posted : January 10, 2011
Last Update Posted : November 25, 2014
Information provided by (Responsible Party):
Janssen Research & Development, LLC